Medical Breathable Tapes Market by 2026 Growth Rate, Sales, Production, Consumption Manufacturers, Market Shares
Poly
adenosine diphosphate ribose polymerase (PARP) is a family of
17 enzymes that combine several (poly) units of ADP-ribose in a chain
and transfer them to the target proteins. These proteins aid in
restoring the damage in DNA caused due to various factors such as
exposure to UV rays, radiation, some anti-cancer drugs or other
substances in the environment. PARP inhibitors aid in blocking the
enzyme important for the repair of single stranded breaks in DNA that
effectively destroys cancer cells.
These inhibitors play an effective role in current
cancer-combating strategies, owing to its effectiveness in
eliminating cancer cells as compared to the existing ovarian cancer
treatments. Drugs such as Talazoparib and Veliparib that aid in
treatment of ovarian cancer are in phase III clinical trials. Such
research and development activities is a key factor contributing to
the global poly adenosine diphosphate ribose polymerase market
growth.
Poly Adenosine Diphosphate Ribose
Polymerase Market Regional Insights
North America and Europe are expected to witness
significant growth in the poly adenosine diphosphate ribose
polymerase market over the forecast period. Increasing demand for
approved drugs, owing to high prevalence of various types of cancer
is expected to facilitate growth of the market, in the U.S. For
instance, according to American Cancer Society (ASC), around 164,690
new cases are expected to be diagnosed with prostate cancer in 2018.
New product launches and robust pipeline of PARP
inhibitors is expected to boost the North America, and Europe PARP
inhibitors market growth over the forecast period. For instance,
Clovis Oncology launched Rubraca (Rucaparib) in 2016, and Tesaro,
Inc. launched Zejula (Niraparib) in 2017. Moreover, Lynparza
(Olaparib) manufactured by AstraZeneca Plc was approved by the U.S.
Food & Drug Administration for the treatment of germline
BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2
(HER2)-negative metastatic breast cancer in January 2018.
Poly Adenosine Diphosphate Ribose
Polymerase Market Key Player
Key players operating in the poly adenosine
diphosphate ribose polymerase market include Tesaro Inc., Clovis
Oncology, AstraZeneca, Pfizer, Inc., and AbbVie Inc.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2029
Poly Adenosine Diphosphate Ribose
Polymerase Market Taxonomy
The global poly adenosine diphosphate ribose
polymerase market is segmented on the basis of drug, cancer type,
distribution channel, and region.
By Drug -
-
Olaparib
-
Rucaparib
-
Niraparib
-
Others
By Cancer Type -
-
Prostate Cancer
-
Ovarian Cancer
-
Others
By Distribution Channel -
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
By Region -
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East
-
Africa
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments
Post a Comment